The Medicine Is a Miracle, but Only if You Can Afford Itnews2023-02-07T14:47:34+00:00February 7th, 2023|The New York Times|
How a Drug Company Made $114 Billion by Gaming the U.S. Patent Systemnews2023-01-28T17:39:16+00:00January 28th, 2023|The New York Times|
California Sues Companies Over Insulin Prices, Joining Other Statesnews2023-01-18T17:16:35+00:00January 18th, 2023|The New York Times|
Biden Tries to Reassure Voters on Health Care Costs Before Electionnews2022-10-15T01:03:45+00:00October 15th, 2022|The New York Times|
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Saysnews2022-09-30T20:16:18+00:00September 30th, 2022|The New York Times|
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?news2022-09-30T09:00:20+00:00September 30th, 2022|The New York Times|
A New Shot Guards Against H.I.V., but Access for Africans Is Uncertainnews2022-09-27T07:00:12+00:00September 27th, 2022|The New York Times|
FDA’s Drug Industry Fees Fuel Concerns Over Influencenews2022-09-15T09:00:26+00:00September 15th, 2022|The New York Times|
Fact-Checking Health Claims About the Inflation Reduction Actnews2022-08-20T03:38:07+00:00August 20th, 2022|The New York Times|
The Inflation Reduction Act Is a Huge Health Care Reformnews2022-08-13T18:55:36+00:00August 13th, 2022|The New York Times|
